https://www.vero-biotech.com/wp-content/uploads/2020/05/Vero-Featured.svg
360
480
Nitin Sharma
https://www.vero-biotech.com/wp-content/uploads/2020/11/Vero_Logo_Vector.svg
Nitin Sharma2022-04-27 13:32:542022-05-02 07:50:06Georgia Bio Awards VERO Biotech the 2022 Golden Helix Innovation Award and Deal of the Year Award
https://www.vero-biotech.com/wp-content/uploads/2020/05/Vero-Featured.svg
360
480
Jessie
https://www.vero-biotech.com/wp-content/uploads/2020/11/Vero_Logo_Vector.svg
Jessie2021-12-21 16:44:032022-05-02 16:41:43VERO Biotech Receives Funding from MVM Partners to Accelerate Growth
https://www.vero-biotech.com/wp-content/uploads/2020/05/Vero-Featured.svg
360
480
Nitin Sharma
https://www.vero-biotech.com/wp-content/uploads/2020/11/Vero_Logo_Vector.svg
Nitin Sharma2021-01-25 07:41:522021-01-25 12:34:16VERO Biotech Secures $50 Million Funding from Runway Growth Capital
https://www.vero-biotech.com/wp-content/uploads/2020/05/Vero-Featured.svg
360
480
Nitin Sharma
https://www.vero-biotech.com/wp-content/uploads/2020/11/Vero_Logo_Vector.svg
Nitin Sharma2020-12-22 08:16:382021-01-08 17:34:14FDA Approves Interhospital Patient Transport Use of VERO Biotech’s GENOSYL® Delivery System, Resulting in the Broadest Label in the Inhaled Nitric Oxide Space
https://www.vero-biotech.com/wp-content/uploads/2020/05/Vero-Featured.svg
360
480
m16Dev
https://www.vero-biotech.com/wp-content/uploads/2020/11/Vero_Logo_Vector.svg
m16Dev2020-05-06 15:11:042021-01-08 17:35:54Home Use of GENOSYL® Delivery System (DS) to Administer GENOSYL® (nitric oxide) gas for Inhalation for the Treatment of Pulmonary Hypertension Complicated by COVID-19 Infection Published in American Journal of Respiratory and Critical Care Medicine
https://www.vero-biotech.com/wp-content/uploads/2020/05/Vero-Featured.svg
360
480
m16Dev
https://www.vero-biotech.com/wp-content/uploads/2020/11/Vero_Logo_Vector.svg
m16Dev2020-04-08 00:15:232021-01-08 17:37:49VERO Biotech Commits to Atlanta Healthcare Providers, Patients and Workforce During COVID-19 Pandemic
https://www.vero-biotech.com/wp-content/uploads/2020/05/Vero-Featured.svg
360
480
m16Dev
https://www.vero-biotech.com/wp-content/uploads/2020/11/Vero_Logo_Vector.svg
m16Dev2020-03-26 18:37:582021-01-08 17:40:27FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
https://www.vero-biotech.com/wp-content/uploads/2020/05/Vero-Featured.svg
360
480
m16Dev
https://www.vero-biotech.com/wp-content/uploads/2020/11/Vero_Logo_Vector.svg
m16Dev2020-03-24 18:35:542021-01-08 17:44:24VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
https://www.vero-biotech.com/wp-content/uploads/2020/05/Vero-Featured.svg
360
480
m16Dev
https://www.vero-biotech.com/wp-content/uploads/2020/11/Vero_Logo_Vector.svg
m16Dev2020-01-13 18:32:352021-01-08 17:50:46VERO Biotech, Leaders in the Development of Innovative Technologies for Inhaled Nitric Oxide Delivery, to Present at Biotech Showcase 2020
